Synageva BioPharma Adds $3 Million
Synageva BioPharma Corp., a Waltham, Mass.-based developer of protein therapeutics, has raised $3 million in additional sixth-round funding, bringing the round total to over $33 million. New backers include Hunt BioVentures and Yasuda Enterprise Development. Prior to this round, the company had raised over $50 million from firms like Baker Brothers Investments, Tullis Dickerson and Four Partners. www.syngeva.com
6 May 2009•1 min read
